BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Whereas it is clearly apparent that the hyperactive, uncontrolled kinase activity of the chimeric fusion BCR-ABL proteins is responsible for their oncogenic potential and the development of CML [9,10], the various downstream signaling pathways mediating their transforming ability are not yet fully defined [11,12].